参考文献:1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277鈥?00. CrossRef 2. Williams H, Powell IJ. Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol Biol. 2009;472:439鈥?3. CrossRef 3. Gwede CK, McDermott RJ. Prostate cancer screening decision making under controversy: implications for health promotion practice. Health Promot Pract. 2006;7(1):134鈥?6. CrossRef 4. Minardi D, Galosi AB, Recchioni A, Giammarco L, Polito M, Muzzonigro G. Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients. Urol Int. 2001;67(4):272鈥?2. CrossRef 5. Eschenbach A, Ho R, Murphy G, Cunningham M, Lins N. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 1997. CA Cancer J Clin. 1997;47:261鈥?. CrossRef 6. U.S. Preventive Services Task Force. Screening for Prostate Cancer: US Preventitive Services Task Force Recommendation Statement (DRAFT). 2011. http://www.uspreventiveservicestaskforce.org/uspstf12/prostate/draftrecprostate.htm. Accessed on April 02, 2012. 7. Guide to Clinical Preventive Services. United States Preventive Services Task Force. Alexandria, VA: International Medical Publishing; 2nd ed. 1996:119鈥?4. 8. Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998;36(9):1337鈥?8. CrossRef 9. Chan E, McFall S, Byrd T, et al. A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT. Patient Educ Couns. 2011;84(2):44鈥?1. CrossRef 10. Barry MJ. Screening for prostate cancer--the controversy that refuses to die. N Engl J Med. 26 2009;360(13):1351鈥?. CrossRef 11. Chu K, Tarone R, Freeman H. Trends in prostate cancer mortality among black men and white men in the United States. Cancer. 2003;97(6). 12. Demark-Wahnefried W, Schildkraut JM, Iselin CE, et al. Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. Cancer. 1998;83(2):320鈥?0. CrossRef 13. Dimah K. Prostate cancer among African American men: a review of empirical literature. J Afr Am Stud. 2003;7(1):28鈥?6. 14. Tillman LC. Culturally sensitive research approaches: an African-American perspective. Educ Res. 2002;31(9):3鈥?2. CrossRef 15. Andersen BL. Behavioral outcomes following psychological interventions for cancer patients.J Consult Clin Psychol. 2002;70(3):590鈥?10. CrossRef 16. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS med. 2009;6(7):e1000097. 17. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52(6):377. CrossRef 18. Kripalani S, Sharma J, Justice E, et al. Low-literacy interventions to promote discussion of prostate Cancer: a randomized controlled trial. Am J Prev Med. 2007;33(2):83鈥?0. CrossRef 19. Barber K, Shaw R, Folts M, et al. Differences between African American and Caucasian men participating in a community-based prostate cancer screening program. J Community Health. 1998;23(6):441鈥?1. CrossRef 20. Boehm S, Coleman-Burns P, Schlenk E, Funnell M, Parzuchowski J, Powell I. Prostate cancer in African American men: increasing knowledge and self-efficacy. J Community Health Nurs. 1995;12(3):161鈥?. CrossRef 21. Carter VL, Tippett F, Anderson DL, Tameru B. Increasing prostate cancer screening among African American men. J Health Care for Poor Underserved. 2010;21(3A):91鈥?06. CrossRef 22. Collins M. Increasing prostate cancer awareness in African American men. Oncol Nurs Forum. 1997;24(1):91. 23. Drake B, Shelton R, Gilligan T, Allen J. A church-based intervention to promote informed decision making for prostate cancer screening among African American men. J Natl Med Assoc. 2010;102(3):164鈥?1. 24. Ellison G, Weinrich S, Lou M, Hongyan X, Powell I, Baquet C. A randomized trial comparing web-based decision aids on prostate cancer knowledge for African-American men. J Natl Med Assoc. 2008;100(10):1139鈥?5. 25. Holt C, Wynn T, Litaker M, Southward P, Jeames S, Schulz E. A comparison of a spiritually based and non-spiritually based educational intervention for informed decision making for prostate cancer screening among church-attending African-American men. Urol Nurs. 2009;29(4):249. 26. Powell I, Heilbrun L, Littrup P, et al. Outcome of African American men screened for prostate cancer: The Detroit Education and Early Detection Study. J Urol. 1997;158(1):146鈥?. CrossRef 27. Stephens RL, Xu Y, Volk RJ, et al. Influence of a patient decision aid on decisional conflict related to PSA testing: A structural equation model. Health Psychol. 2008;27(6):711鈥?1. CrossRef 28. Taylor K, Davis J, Turner R, et al. Educating African American men about the prostate cancer screening dilemma: a randomized intervention. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2179. CrossRef 29. Weston R, Weston P, Futterman R, et al. Effectiveness of a modified computer assisted instructional tool in the dissemination of prostate cancer information to men of African descent through black churches. J Afr Am Stud. 2007;11(2):140鈥?6. CrossRef 30. Wilkinson S, List M, Sinner M, Dai L, Chodak G. Educating African-American men about prostate cancer: impact on awareness and knowledge. Urology. 2003;61(2):308鈥?3. CrossRef 31. Husaini B, Reece M, Emerson J, Scales S, Hull P, Levine R. A church-based program on prostate cancer screening for African American men: reducing health disparities. Ethn Dis. 2008;18:179鈥?4. 32. Powell I, Gelfand D, Parzuchowski J, Heilbrun L, Franklin A. A successful recruitment process of African American men for early detection of prostate cancer. Cancer. 1995;75(S7):1880鈥?. CrossRef 33. Penedo F, Dahn J, Molton I, et al. Cognitive behavioral stress management improves stress management skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer. 2004;100(1):192鈥?00. CrossRef 34. Penedo F, Traeger L, Dahn J, et al. Cognitive behavioral stress management intervention improves quality of life in Spanish monolingual Hispanic men treated for localized prostate cancer: results of a randomized controlled trial. Int J Behav Med. 2007;14(3):164鈥?2. CrossRef 35. Campbell L, Keefe F, Scipio C, et al. Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. Cancer. 2007;109(S2):414鈥?4. CrossRef 36. Antoni MH. Stress management effects on psychological, endocrinological, and immune functioning in men with HIV infection: empirical support for a psychoneuroimmunological model. Stress: Int J Biol Stress. 2003;6(3):173鈥?8. CrossRef 37. Mishel M, Belyea M, Germino B, et al. Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects. Cancer. 2002;94(6):1854鈥?6. CrossRef 38. Mishel M, Germino B, Lin L, et al. Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns. 2009;77(3):349鈥?9. CrossRef 39. Partin MR, Nelson D, Radosevich D, et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med. 2004;19(8):835鈥?2. CrossRef 40. Volk RJ, Hawley ST, Kneuper S, et al. Trials of decision aids for prostate cancer screening: a systematic review. Am j prev med. 2007;33(5):428鈥?4. e411. CrossRef 41. Evans R, Joseph-Williams N, Edwards A, et al. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial. J Med Internet Res. 2010;12(3). 42. Handley MR, Stuart ME. The use of prostate specific antigen for prostate cancer screening: a managed care perspective. J Urol. 1994;152(5 Pt 2):1689. 43. Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psycho-Oncol. 2002;11(4):307鈥?6. CrossRef 44. Penedo FJ, Dahn JR, Shen BJ, Schneiderman N, Antoni MH. Ethnicity and determinants of quality of life after prostate cancer treatment. Urology. 2006;67(5):1022鈥?. CrossRef 45. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CAPSURE. Urology. 1999;54(3):503鈥?. CrossRef 46. Melmed GY, Kwan L, Reid K, Litwin MS. Quality of life at the end of life: trends in patients with metastatic prostate cancer. Urology. 2002;59(1):103鈥?. CrossRef 47. Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 2003;22(5):443. CrossRef 48. Kon AA. The shared decision-making continuum. JAMA: J Am Med Assoc. 2010;304(8):903鈥?. CrossRef 49. Sajid S, Mohile SG, Szmulewitz R, Posadas E, Dale W. Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum. Semin Oncol. 2011;38(2):309鈥?5. CrossRef
作者单位:Saleha Sajid MD (1) (2) Ashwin A. Kotwal BA (1) William Dale MD, PhD (1) (2)
1. Department of Medicine, Section of Geriatrics & Palliative Medicine, University of Chicago Medical Center, 5841 S. Maryland Avenue, MC6098, Chicago, IL, 60637, USA 2. Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, USA